The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab for previously treated advanced cervical squamous cell cancer: Preliminary results from the phase 2 KEYNOTE-158 study.
 
Jan H.M. Schellens
No Relationships to Disclose
 
Aurelien Marabelle
Honoraria - Bristol-Myers Squibb; Genentech; Merck; Roche
Consulting or Advisory Role - Amgen; Genentech; Novartis; Roche
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Merck; Roche
Research Funding - Merus (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche
 
Susan Zeigenfuss
Employment - Merck
 
Jie Ding
Employment - Merck
 
Scott Knowles Pruitt
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Hyun Cheol Chung
Consulting or Advisory Role - Bristol-Myers Squibb; Celltrion; Lilly; MSD; Quintiles; Taiho Pharmaceutical
Speakers' Bureau - Lilly; Merck Serono
Research Funding - GlaxoSmithKline; Lilly; MSD